Advertisement
Screener

Hartford Financial Management Inc. Historic Quarter Change: Foreign ADRs, Reduced

Hartford Financial Management Inc. historic quarter change: Foreign ADRs, Reduced

In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 23 quarters from 2013-06-30 to 2026-06-30, Hartford Financial Management Inc. opened 12 positions, added to 1, reduced 4 and sold out of 12.

  • Q3 2016: Stock Shire Pharmaceuticals GR-ADR; Country of operation —; Class SPONS ADR; Shares before 2,025.
  • Q4 2014: Stock Astrazeneca PLC-Spons ADR; Country of operation —; Class SPONS ADR; Shares before 1,204.
  • Q2 2014: Stock Glaxo Hldg Plc ADR; Country of operation —; Class SPONS ADR; Shares before 910.
  • Q3 2013: Stock Glaxo Hldg Plc ADR; Country of operation —; Class SPONS ADR; Shares before 1,098.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1352526), 23 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-07-24); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-04-16); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-01-21); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-10-28); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-07-31); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-04-21); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-01-23); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-10-28); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-09); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-04-24); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-10-25); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-07-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-04-20); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-01-28); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-10-28); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-07-07); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-04-13); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-09); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-10-29); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-05); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-07); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-01-31); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-10-30). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2005-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q3 2016Shire Pharmaceuticals GR-ADR
CUSIP 82481R106
SPONS ADR2,0251,977-48$372,000$383,000+$11,0002016-10-25
Q4 2014Astrazeneca PLC-Spons ADR
CUSIP 046353108
SPONS ADR1,20435-1,169$2,000$2,000$02015-02-09
Q2 2014Glaxo Hldg Plc ADR
CUSIP 37733W105
SPONS ADR910800-110$48,000$42,000-$6,0002014-08-05
Q3 2013Glaxo Hldg Plc ADR
CUSIP 37733W105
SPONS ADR1,098910-188$55,000$45,000-$10,0002013-10-30

Similar Firms

Firm NameCountry13F ValueHoldings
Divisar Capital Management LLCUnited States$0.392B26
RIPOSTE CAPITAL LLCUnited States$0.392B24
Wellington Shields & Co., LLCUnited States$0.392B321
Sunflower Bank, N.A.United States$0.392B221
Euclidean Capital LLCUnited States$0.392B10
HIGHLINE WEALTH PARTNERS LLCUnited States$0.392B1,298
Level Financial AdvisorsUnited States$0.392B92
Boltwood Capital ManagementUnited States$0.392B184
Hollow Brook Wealth Management LLCUnited States$0.392B70
Eldred Rock Partners, LLCUnited States$0.393B31